LYN-MARIE KUBALL: Open Payments
NPI 1922632702 · LITTLE RIVER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 22 payments from 13 companies in 2025. Trend: 2023 $292 · 2024 $363 · 2025 $513
Food & beverage: $401Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $126 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Xeris Pharmaceuticals, Inc. | 3 | $62 |
| Braeburn Inc. | 2 | $47 |
| Indivior Inc. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| ABBVIE INC. | 2 | $29 |
| Tonix Medicines, Inc. | 1 | $25 |
| Corcept Therapeutics | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: REXULTI, GVOKE HYPOPEN, BRIXADI, SUBLOCADE, FARXIGA, VRAYLAR, ZEMBRACE SYMTOUCH, Korlym.
Industry payments across SC — which companies pay providers there.
